Clinical Trial

BE.Amycon Biobank & Data Registry UZ Leuven

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with amyloidosis in a database "BE.Amycon data registry".
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-10.
Status change: Not Yet Recruiting → Recruiting 2026-02-23
Trial Details
NCT Number NCT07172243
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Collaborators: Flemish institute of biotechnology (VIB)
Conditions Amyloidosis, AL Amyloidosis, Amyloidosis Cardiac
Enrollment 505 participants
Start Date 2025-09-24
Primary Completion 2029-09 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27